带生物银行的进展:对当前趋势和未来前景的全面审查
Sahar AlOraibi1, Sebastien Taurin1, Sfoug Alshammary1
1Molecular Medicine Department, Princess Al Jawhara Center for Molecular Medicine, Genetics, and Hereditary Diseases, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Bahrain.
Stem cells and cloning : advances and applications
|December 10, 2024
概括
带 (UC) 生物银行为移植提供了有价值的干细胞. 优化UC处理,质量控制和利用AI对于推进再生医学和全球生物银行网络至关重要.
科学领域:
- 再生医学是一种再生医学.
- 生物技术是生物技术.
- 干细胞生物学 干细胞生物学
背景情况:
- 带 (UC) 生物银行正在迅速扩大,提供丰富的造血干细胞 (HSC) 和介质干细胞 (MSC) 的来源.
- 在临床移植中,UC衍生干细胞比成年干细胞来源具有优势.
- 实现充分的治疗潜力需要优化处理,冷保存,质量控制和监管框架.
研究的目的:
- 审查UC生物银行领域的进展,重点关注安全,质量控制和标准化.
- 探索优化和自动化的UC处理和冷保存技术.
- 检查扩展的临床应用,挑战和AI在UC生物银行中的作用.
主要方法:
- 关于UC生物银行近期进展的综合文献综述.
- 分析安全,质量控制和标准化协议.
- 在生物银行业务和数据分析中探索人工智能应用.
主要成果:
- 最近的进展侧重于严格的安全和质量控制程序.
- 生物银行业务的标准化和加工/冷保存的自动化是关键.
- 扩大UC干细胞的临床应用正在出现,与AI整合一起.
结论:
- 优化UC生物银行业务对于推进再生医学至关重要.
- 标准化,自动化和人工智能集成对于未来的UC生物银行网络至关重要.
- 解决UC生物银行和疗法的挑战将增强其临床影响.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...


